ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Onconetix, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.43−0.05 (-10.13%)
Close on Oct 19, 2026
- Market cap
- $965.06K
- P/E (TTM)
- –
- Dividend yield
- –
Onconetix, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q4 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Development Services [Member] | – | – | – | $52 | $64 | $1.51K | $542.39K | $404.29K | $704.85K | $622.99K | – | – | – | – |
| Product Sales [Member] | – | – | $5.38K | $7.38K | $106.49K | $100.12K | $169.59K | $2.57K | – | $77.45K | – | – | – | – |
| Product Sales [Member] | – | – | – | – | $100.00K | – | – | $0 | $700.00K | – | – | – | – | – |
| Other revenue [Member] | – | – | – | $296.27K | – | – | – | – | – | – | – | – | – | – |
| License [Member] | – | – | – | $300.00K | – | – | – | – | – | – | – | – | – | – |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q4 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Switzerland | $10.32K | – | $301.21K | $296.27K | $104.21K | $94.38K | $704.46K | $405.07K | $704.85K | $622.99K | – | – | 60.3% | -90.1% |
| United Kingdom | $6.80K | $21.46K | $2.39K | $7.38K | $2.28K | $7.25K | $11.13K | $1.79K | – | $13.95K | – | – | 39.7% | +198.0% |
| United States | – | – | – | – | – | – | – | $1.21K | $2.02K | $63.50K | – | – | – | – |
| European Union [Member] | – | – | $301.21K | $296.27K | $104.21K | $94.38K | $704.46K | $404.29K | $704.85K | $622.99K | – | – | – | – |
| Non-European Union (UK) [Member] | – | – | $2.39K | $7.38K | $2.28K | $7.25K | $11.13K | $2.57K | – | $13.95K | – | – | – | – |
From the segment and revenue-disaggregation notes of Onconetix's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.